Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words '311C90' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 66 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gruffyd-Jones, K; Kies, B; Middleton, A; Mulder, LJMM; Rosjo, O; Millson, DS
      Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study

      EUROPEAN JOURNAL OF NEUROLOGY
    2. Gawel, MJ; Worthington, I; Maggisano, A
      Progress in clinical neurosciences - A systematic review of the use of triptans in acute migraine

      CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    3. Jhee, SS; Shiovitz, T; Crawford, AW; Cutler, NR
      Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents -A comparative review

      CLINICAL PHARMACOKINETICS
    4. Linder, SL; Dowson, AJ
      Zolmitriptan provides effective migraine relief in adolescents

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    5. Ryan, RE; Diamond, S; Giammarco, RAM; Aurora, SK; Reed, RC; Fletcher, PE
      Efficacy of zolmitriptan at early time-points for the acute treatment of migraine and treatment of recurrence - A randomised, placebo-controlled trial

      CNS DRUGS
    6. Nappi, G; Johnson, FN
      The clinical efficacy of zolmitriptan

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    7. Edmeads, J; Johnson, FN
      The adverse event and tolerability profile of zolmitriptan

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    8. Mick, G
      Physiopathology of the migraine attack and the mechanisms of action of antimigraine agents: recent findings in animals

      PATHOLOGIE BIOLOGIE
    9. Geraud, G; Olesen, J; Pfaffenrath, V; Tfelt-Hansen, P; Zupping, R; Diener, HC; Sweet, R
      Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design

      CEPHALALGIA
    10. de Tommaso, M; Guido, M; Libro, G; Sciruicchio, V; Puca, F
      Zolmitriptan reverses blink reflex changes induced during the migraine attack in humans

      NEUROSCIENCE LETTERS
    11. Deleu, D; Hanssens, Y
      Current and emerging second-generation triptans in acute migraine therapy:A comparative review

      JOURNAL OF CLINICAL PHARMACOLOGY
    12. Sturzenegger, M; Daems, K; Billeter, M
      Zolmitriptan in the treatment of migraine attacks - the ARES study

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    13. Boers, PM; Donaldson, C; Zagami, AS; Lambert, GA
      5-HT1A and 5-HT1B/1D receptors are involved in the modulation of the trigeminovascular system of the cat: a microiontophoretic study

      NEUROPHARMACOLOGY
    14. Bahra, A; Gawel, MJ; Hardebo, JE; Millson, D; Breen, SA; Goadsby, PJ
      Oral zolmitriptan is effective in the acute treatment of cluster headache

      NEUROLOGY
    15. Gallagher, RM; Dennish, G; Spierings, ELH; Chitra, R
      A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine

      HEADACHE
    16. Le Grand, B; Panissie, A; Perez, M; Pauwels, PJ; John, GW
      Zolmitriptan stimulates a Ca2+-dependent K+ current in C6 glioma cells stably expressing recombinant human 5-HT1B receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    17. Diener, HC; Limmroth, V
      Acute management of migraine: triptans and beyond

      CURRENT OPINION IN NEUROLOGY
    18. Dixon, R; Engleman, K; Kemp, J; Ruckle, JL
      A comparison of the pharmacokinetics and tolerability of the novel antimigraine compound zolmitriptan in adolescents and adults

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    19. Le Jeunne, C
      Zolmitriptan

      PRESSE MEDICALE
    20. Diener, HC; Kaube, H; Limmroth, V
      Antimigraine drugs

      JOURNAL OF NEUROLOGY
    21. Jhee, SS; Salazar, DE; Ford, NF; Fulmor, IE; Sramek, JJ; Cutler, NR
      A double-blind, randomized, crossover assessment of blood pressure following administration of avitriptan, sumatriptan, or placebo to patients with mild to moderate hypertension

      CEPHALALGIA
    22. Hughes, AM; Dixon, R; Dane, A; Kemp, J; Cummings, L; Yates, RA
      Effects of zolmitriptan (Zomig (TM)) on central serotonergic neurotransmission as assessed by active oddball auditory event-related potentials in volunteers without migraine

      CEPHALALGIA
    23. Roon, KI; Sandor, PS; Schoonman, GG; Lamers, FPL; Schoenen, J; Ferrari, MD; van Dijk, JG
      Auditory evoked potentials in the assessment of central nervous system effects of antimigraine drugs

      CEPHALALGIA
    24. Storer, RJ; Goadsby, PJ
      Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamate receptors

      NEUROSCIENCE
    25. Deleu, D; Hanssens, Y
      Profiles of 5-HT1B/1D agonists in acute migraine with special reference tosecond generation agents

      ACTA NEUROLOGICA BELGICA
    26. Tepper, SJ; Donnan, GA; Dowson, AJ; Bomhof, MAM; Elkind, A; Meloche, J; Fletcher, PE; Millson, DS
      A long-term study to maximise migraine relief with zolmitriptan

      CURRENT MEDICAL RESEARCH AND OPINION
    27. Tuchman, M; Edvinsson, L; Geraud, G; Korczyn, A; Mauskop, A; Pfaffenrath, V
      Zolmitriptan provides consistent migraine relief when used in the long term

      CURRENT MEDICAL RESEARCH AND OPINION
    28. Mauskop, A; Farkkila, M; Hering-Hanit, R; Rapoport, A; Warner, J
      Zolmitriptan is effective for the treatment of persistent and recurrent migraine headache

      CURRENT MEDICAL RESEARCH AND OPINION
    29. Dahlof, CGH; Rapoport, AM; Sheftell, FD; Lines, CR
      Rizatriptan in the treatment of migraine

      CLINICAL THERAPEUTICS
    30. Sharma, A; Jusko, WJ; Fulmor, IE; Norton, J; Uderman, HD; Salazar, DE
      Pharmacokinetics and pharmacodynamics of avitriptan during intravenous administration in healthy subjects

      JOURNAL OF CLINICAL PHARMACOLOGY
    31. Wild, MJ; McKillop, D; Butters, CJ
      Determination of the human cytochrome P450 isoforms involved in the metabolism of zolmitriptan

      XENOBIOTICA
    32. Klein, KB
      A triptan too far?

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    33. Kemp, DM; George, SE; Bungay, PJ; Naylor, LH
      Partial agonism at serotonin 5-HT1B and dopamine D-2L receptors using a luciferase reporter gene assay

      EUROPEAN JOURNAL OF PHARMACOLOGY
    34. Nilsson, T; Longmore, J; Shaw, D; Pantev, E; Bard, JA; Branchek, T; Edvinsson, L
      Characterisation of 5-HT receptors in human coronary arteries by molecularand pharmacological techniques

      EUROPEAN JOURNAL OF PHARMACOLOGY
    35. Spencer, CM; Gunasekara, NS; Hills, C
      Zolmitriptan - A review of its use in migraine

      DRUGS

    36. Zolmitriptan - New product similar to sumatriptan

      CANADIAN FAMILY PHYSICIAN
    37. Limmroth, V; Diener, HC
      New anti-migraine drugs: Present and beyond the millennium

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    38. DAHLOF C; DIENER HC; GOADSBY PJ; MASSIOU H; OLESEN J; SCHOENEN J; WILKINSON M; SWEET RM; KLEIN KB
      ZOLMITRIPTAN, A 5-HT1B 1D RECEPTOR AGONIST FOR THE ACUTE ORAL TREATMENT OF MIGRAINE - A MULTICENTER, DOSE-RANGE FINDING STUDY/

      European journal of neurology
    39. DIXON R; HUGHES AM; NAIRN K; SELLERS M; KEMP JV; YATES RA
      EFFECTS OF THE ANTIMIGRAINE COMPOUND ZOLMITRIPTAN (ZOMIG) ON PSYCHOMOTOR PERFORMANCE ALONE AND IN COMBINATION WITH DIAZEPAM IN HEALTHY-VOLUNTEERS

      Cephalalgia
    40. SEABER EJ; PECK RW; SMITH DA; ALLANSON J; HEFTING NR; VANLIER JJ; SOLLIE FAE; WEMER J; JONKMAN JHG
      THE ABSOLUTE BIOAVAILABILITY AND EFFECT OF FOOD ON THE PHARMACOKINETICS OF ZOLMITRIPTAN IN HEALTHY-VOLUNTEERS

      British journal of clinical pharmacology
    41. SMITH DA; CLEARY EW; WATKINS S; HUFFMAN CS; DILZER SC; LASSETER KC
      PHARMACOKINETICS AND PHARMACODYNAMICS OF ZOLMITRIPTAN IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

      Journal of clinical pharmacology
    42. DIXON R; FRENCH S; KEMP J; SELLERS M; LECLERC T; DELVAUX M; RAUTUREAU J
      EFFECT OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS OF ZOLMITRIPTAN

      Journal of clinical pharmacology
    43. WERHAHN KJ; FORDERREUTHER S; STRAUBE A
      EFFECTS OF THE SEROTONIN( 1B 1D) RECEPTOR AGONIST ZOLMITRIPTAN ON MOTOR CORTICAL EXCITABILITY IN HUMANS/

      Neurology
    44. MacGregor, EA
      Zolmitriptan clinical studies

      DRUGS OF TODAY
    45. GOADSBY PJ
      A TRIPTAN TOO FAR

      Journal of Neurology, Neurosurgery and Psychiatry
    46. Cumberbatch, MJ; Hill, RG; Hargreaves, RJ
      The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    47. MacLennan, SJ; Cambridge, D; Whiting, MV; Marston, C; Martin, GR
      Cranial vascular effects of zolmitriptan, a centrally active 5-HT1B/1D receptor partial agonist for the acute treatment of migraine

      EUROPEAN JOURNAL OF PHARMACOLOGY
    48. PECK RW; SEABER EJ; DIXON RM; LAYTON GR; WEATHERLEY BC; JACKSON SHD; ROLAN PE; POSNER J
      THE PHARMACODYNAMICS AND PHARMACOKINETICS OF THE 5HT(1B 1D)-AGONIST ZOLMITRIPTAN IN HEALTHY-YOUNG AND ELDERLY MEN AND WOMEN/

      Clinical pharmacology and therapeutics
    49. Mercer, AJ; Lamb, RJ; Rolan, PE; Gibbens, M; Posner, J
      Lack of an effect of zolmitriptan (Zomig, 311C90) on psychometric task performance: results of a placebo-controlled study in healthy volunteers

      PSYCHOPHARMACOLOGY
    50. VERONESE L; GILLOTIN C; MARIONGALLOIS R; WEATHERLEY BC; THEBAULT JJ; GUILLAUME M; PECK RW
      LACK OF INTERACTION BETWEEN ORAL DIHYDROERGOTAMINE AND THE NOVEL ANTIMIGRAINE COMPOUND ZOLMITRIPTAN IN HEALTHY-VOLUNTEERS

      Clinical drug investigation
    51. SEABER EJ; GILLOTIN C; MOHANLAL R; LAYTON G; POSNER J; PECK R
      LACK OF INTERACTION BETWEEN PIZOTIFEN AND THE NOVEL ANTIMIGRAINE COMPOUND ZOLMITRIPTAN IN HEALTHY-VOLUNTEERS

      Clinical drug investigation
    52. GILLOTIN C; BAGNIS C; MAMET JP; PECK RW; DERAY G
      NO NEED TO ADJUST THE DOSE OF 311C90 (ZOLMITRIPTAN), A NOVEL ANTIMIGRAINE TREATMENT, IN PATIENTS WITH RENAL-FAILURE NOT REQUIRING DIALYSIS

      International journal of clinical pharmacology and therapeutics
    53. DIXON R; WARRANDER A
      THE CLINICAL PHARMACOKINETICS OF ZOLMITRIPTAN

      Cephalalgia
    54. SEABER E; ON N; DIXON RM; GIBBENS M; LEAVENS WJ; LIPTROT J; CHITTICK G; POSNER J; ROLAN PE; PECK RW
      THE ABSOLUTE BIOAVAILABILITY AND METABOLIC DISPOSITION OF THE NOVEL ANTIMIGRAINE COMPOUND ZOLMITRIPTAN (311C90)

      British journal of clinical pharmacology
    55. DIXON R; GILLOTIN C; GIBBENS M; POSNER J; PECK RW
      THE PHARMACOKINETICS AND EFFECTS ON BLOOD-PRESSURE OF MULTIPLE DOSES OF THE NOVEL ANTIMIGRAINE DRUG ZOLMITRIPTAN (311C90) IN HEALTHY-VOLUNTEERS

      British journal of clinical pharmacology
    56. SOLOMON GD; CADY RK; KLAPPER JA; EARL NL; SAPER JR; RAMADAN NM
      CLINICAL EFFICACY AND TOLERABILITY OF 2.5 MG ZOLMITRIPTAN FOR THE ACUTE TREATMENT OF MIGRAINE

      Neurology
    57. MARTIN GR; ROBERTSON AD; MACLENNAN SJ; PRENTICE DJ; BARRETT VJ; BUCKINGHAM J; HONEY AC; GILES H; MONCADA S
      RECEPTOR SPECIFICITY AND TRIGEMINO-VASCULAR INHIBITORY ACTIONS OF A NOVEL 5-HT1B 1D RECEPTOR PARTIAL AGONIST, 311C90 (ZOLMITRIPTAN)/

      British Journal of Pharmacology
    58. SEABER E; ON N; PHILLIPS S; CHURCHUS R; POSNER J; ROLAN P
      THE TOLERABILITY AND PHARMACOKINETICS OF THE NOVEL ANTIMIGRAINE COMPOUND 311C90 IN HEALTHY MALE-VOLUNTEERS

      British journal of clinical pharmacology
    59. EDMEADS JG
      MIGRAINE - BETTER UNDERSTANDING, BETTER TREATMENT

      European neurology
    60. FERRARI MD
      THE CLINICAL EFFECTIVENESS OF 311C90 IN THE ACUTE TREATMENT OF MIGRAINE

      European neurology
    61. EARL NL
      CLINICAL SAFETY OF 311C90 - AGGREGATED DATA FROM PATIENTS AND VOLUNTEERS TO DATE

      European neurology
    62. MARTIN GR
      INHIBITION OF THE TRIGEMINO-VASCULAR SYSTEM WITH 5-HT1D AGONIST DRUGS- SELECTIVELY TARGETING ADDITIONAL SITES OF ACTION

      European neurology
    63. FERRARI MD; MARTIN GR; EARL NL; KLEIN KB
      EMERGING PRECLINICAL AND CLINICAL PROFILE OF 311C90 - A POSTER REVIEWAND DISCUSSION

      European neurology
    64. GERAUD GEA
      EVALUATION OF THE LONG-TERM SAFETY AND EFFICACY OF 311C90 IN THE TREATMENT OF MIGRAINE

      European neurology
    65. DOWSON A
      CAN ORAL 311C90, A NOVEL 5-HT1D AGONIST, PREVENT MIGRAINE HEADACHE WHEN TAKEN DURING AN AURA

      European neurology
    66. EDMEADS JG
      EXTENDING THERAPEUTIC OPTIONS - PROSPECTS FOR THE FUTURE

      European neurology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 07:01:43